Clinical Trials List
Protocol NumberFP02C-14-001
2014-10-01 - 2016-09-30
Phase I
Terminated1
-
Trial Applicant
QPS
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chern-En Chiang Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
80 participants
